Project Description
Luoda has invented, patented, developed, registered and manufactured a novel oral liquid formulation of pimobendan to improve ease and reliability of administration, compliance and effectiveness.
Target
Congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation) in dogs.
Project Details
| Development Status: | Registration submitted |
| Licence Status: | Partner / funding secured |
| Commercialisation Date: | November 2016 |